These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7940348)

  • 21. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial.
    Antoni C; Krueger GG; de Vlam K; Birbara C; Beutler A; Guzzo C; Zhou B; Dooley LT; Kavanaugh A;
    Ann Rheum Dis; 2005 Aug; 64(8):1150-7. PubMed ID: 15677701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial.
    Kaltwasser JP; Nash P; Gladman D; Rosen CF; Behrens F; Jones P; Wollenhaupt J; Falk FG; Mease P;
    Arthritis Rheum; 2004 Jun; 50(6):1939-50. PubMed ID: 15188371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Deresinated naphthalan in the treatment of psoriatic arthritis].
    Grigor'eva VD; Badalov NG
    Vopr Kurortol Fizioter Lech Fiz Kult; 1994; (4):13-5. PubMed ID: 7846875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caffeine consumption and methotrexate dosing requirement in psoriasis and psoriatic arthritis.
    Swanson DL; Barnes SA; Mengden Koon SJ; el-Azhary RA
    Int J Dermatol; 2007 Feb; 46(2):157-9. PubMed ID: 17269967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical pharmacology of the new Soviet anti-inflammatory preparation ortofen].
    Kukes VG; Murashko VV; Iagunina MV; Volchenok VI; Pokryshkin VI
    Ter Arkh; 1988; 60(3):105-9. PubMed ID: 3388258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
    Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
    Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-alpha and diclofenac in rheumatoid arthritis.
    Dugina JL; Petrov VI; Babayeva AR; Martyushev-Poklad AV; Tcherevkova EV; Epstein OI; Sergeeva SA
    Int J Tissue React; 2005; 27(1):15-21. PubMed ID: 15847101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry.
    Nast A; Reytan N; Rosumeck S; Erdmann R; Rzany B
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1337-42. PubMed ID: 18624864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxaprozin versus diclofenac in NSAID-refractory periarthritis pain of the shoulder.
    Heller B; Tarricone R
    Curr Med Res Opin; 2004 Aug; 20(8):1279-90. PubMed ID: 15324531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diclofenac combined with cyclosporine in treatment refractory rheumatoid arthritis: longitudinal safety assessment and evidence of a pharmacokinetic/dynamic interaction.
    Kovarik JM; Kurki P; Mueller E; Guerret M; Markert E; Alten R; Zeidler H; Genth-Stolzenburg S
    J Rheumatol; 1996 Dec; 23(12):2033-8. PubMed ID: 8970037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial.
    Pavelka K; Recker DP; Verburg KM
    Rheumatology (Oxford); 2003 Oct; 42(10):1207-15. PubMed ID: 12810937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: efficacy, safety and impact on patients' quality of life.
    De Felice C; Mazzotta A; Esposito M; Bianchi L; Chimenti S
    J Dermatolog Treat; 2006; 17(6):355-8. PubMed ID: 17853309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey.
    Radtke MA; Reich K; Blome C; Rustenbach S; Augustin M
    J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):683-91. PubMed ID: 19309433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M
    Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacy and tolerability of two diclofenac formulations in the treatment of painful osteoarthritis.
    Bakshi R
    Br J Clin Pract; 1996 Sep; 50(6):294-7. PubMed ID: 8983316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and tolerability of aceclofenac in the treatment of patients with ankylosing spondylitis: a multicenter controlled clinical trial. Aceclofenac Indomethacin Study Group.
    Batlle-Gualda E; Figueroa M; Ivorra J; Raber A
    J Rheumatol; 1996 Jul; 23(7):1200-6. PubMed ID: 8823693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs.
    Cantini F; Niccoli L; Nannini C; Cassarà E; Pasquetti P; Olivieri I; Salvarani C
    Rheumatology (Oxford); 2008 Jun; 47(6):872-6. PubMed ID: 18400836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab.
    Cauza E; Spak M; Cauza K; Hanusch-Enserer U; Dunky A; Wagner E
    Rheumatol Int; 2002 Nov; 22(6):227-32. PubMed ID: 12426660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis.
    Gisondi P; Girolomoni G; Sampogna F; Tabolli S; Abeni D
    Eur J Dermatol; 2005; 15(4):279-83. PubMed ID: 16048759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of lornoxicam for acute postoperative pain relief after septoplasty: a comparison with diclofenac, ketoprofen, and dipyrone.
    Sener M; Yilmazer C; Yilmaz I; Bozdogan N; Ozer C; Donmez A; Arslan G
    J Clin Anesth; 2008 Mar; 20(2):103-8. PubMed ID: 18410864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.